2025-06-01 2026-05-31 false No description of principal activity Acting Office - Tax and Accounts 1.0 14868297 bus:FullAccounts 2025-06-01 2026-05-31 14868297 bus:Micro-entities 2025-06-01 2026-05-31 14868297 bus:AuditExempt-NoAccountantsReport 2025-06-01 2026-05-31 14868297 bus:SmallCompaniesRegimeForAccounts 2025-06-01 2026-05-31 14868297 bus:PrivateLimitedCompanyLtd 2025-06-01 2026-05-31 14868297 2025-06-01 2026-05-31 14868297 2026-05-31 14868297 bus:RegisteredOffice 2025-06-01 2026-05-31 14868297 core:WithinOneYear 2026-05-31 14868297 core:AfterOneYear 2026-05-31 14868297 2024-06-01 14868297 bus:Director1 2025-06-01 2026-05-31 14868297 bus:Director1 2026-05-31 14868297 bus:Director1 2024-06-01 2025-05-31 14868297 bus:CompanySecretary1 2025-06-01 2026-05-31 14868297 bus:LeadAgentIfApplicable 2025-06-01 2026-05-31 14868297 2024-06-01 2025-05-31 14868297 2025-05-31 14868297 core:WithinOneYear 2025-05-31 14868297 core:AfterOneYear 2025-05-31 14868297 bus:EntityAccountantsOrAuditors 2024-06-01 2025-05-31 14868297 core:CostValuation core:Non-currentFinancialInstruments 2026-05-31 14868297 core:CostValuation core:Non-currentFinancialInstruments 2025-05-31 14868297 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-05-31 14868297 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-05-31 14868297 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-05-31 14868297 core:ShareProfitOrLossIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-05-31 14868297 core:ProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-05-31 14868297 core:ImpairmentReversalProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-05-31 14868297 core:ForeignExchangeDifferencesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-05-31 14868297 core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-05-31 14868297 core:TransfersBetweenInvestmentClassesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-05-31 14868297 core:Non-currentFinancialInstruments 2026-05-31 14868297 core:Non-currentFinancialInstruments 2025-05-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 14868297
England and Wales

 

 

 


Unaudited Financial Statements

for the year ended 31 May 2026

for

CULTUREVATING LTD

 
 
 
£
2026
£
   
£
2025
£
Current assets 4,143  10,723 
Creditors: amount falling due within one year (2,577) (5,973)
Net current assets/(liabilities) 1,566  4,750 
Total assets less current liabilities 1,566  4,750 
Net assets/(liabilities) 1,566  4,750 
 
Capital and reserves 1,566  4,750 
 



Notes to the Accounts
Statutory Information
Culturevating Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number 14868297, registration address 12 Dorset Gardens, Brighton, BN2 1RL, United Kingdom.

The presentation currency is £ sterling.
1.

Accounting Policies

Basis of accounting
The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
2.

Average number of employees

Average number of employees during the year was 1 (2025: 1).

Director's Responsibilities:
  1. For the year ended 31 May 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
  2. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions.

Signed on behalf of the board of directors:


---------------------------------------------
Alex David Kammerling
Director

Date approved: 23 July 2026
1